ADVM Adverum Biotechnologies Inc

Adverum Biotechnologies Inc is a gene therapy company committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye.

$12.15  -1.17 (-8.78%)
As of 03/02/2021 15:59:53 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
07/31/2014
97,477,603
660,827
$1,298,401,672
0.00%
SEC Edgar Online
10-Q
10-K
00773U108
US00773U1088
BD6NXD7

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
2.79
0.00
-21.26%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy